Latest updates for Jsgrx

Fresh curated links around JSGRX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • UroGen Pharma: An Emerging GARP Stock
  • John Hancock U.S. Growth Fund Q2 2026 Commentary
  • GSK: Still One Of My Top Healthcare Picks

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

seekingalpha.com /1 week ago

UroGen Pharma: An Emerging GARP Stock

Read source
seekingalpha.com /4 weeks ago

John Hancock U.S. Growth Fund Q2 2026 Commentary

Read source
seekingalpha.com /1 month ago

GSK: Still One Of My Top Healthcare Picks

Read source
seekingalpha.com /4 weeks ago

Japan Gold Corp. (JG:CA) Presents at Precious Metals Summit Beaver Creek 2026 - Slideshow

Read source
seekingalpha.com /1 month ago

Pharming wins approval of Joenja for younger age group

Read source
cafepharma.com /1 week ago

Jax Jeff

Jax Jeff Anonymous (not verified) Fri, 10/09/2026 - 07:09 field_thread_url https://cafepharma.com/boards/threads/jax-jeff.671347/ board...

Read source
seekingalpha.com /1 month ago

Journey Medical: A Small Pharma With A Large Growth Opportunity

Read source
seekingalpha.com /9 hours ago

J Sainsbury plc (JSAIY) Q2 2027 Earnings Call Transcript

Read source
seekingalpha.com /1 month ago

SpyGlass Pharma, Inc. (SGP) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript

Read source
seekingalpha.com /1 day ago

Compass Pathways: Built The FDA's Way, Valued At 0.57x Spravato's Sales

Read source
seekingalpha.com /1 month ago

Janus Henderson Overseas Fund Q2 2026 Commentary

Read source
seekingalpha.com /1 month ago

Janus Henderson Triton Fund Q2 2026 Commentary

Read source
fool.com /1 month ago

2 Stocks That Could Capitalize on the GLP-1 Boom

They aren't the most prominent names in the GLP-1 space, but they are worth a second look.

Read source
seekingalpha.com /3 weeks ago

GRNJ: Fundstrat's High-Risk Strategy Is Starting To Hurt

Read source
pharmexec.com /1 week ago

<![CDATA[Roundup: TRexBio & Retension Pharmaceuticals Announce IPO Pricing ]]>

Read source
fool.com /1 month ago

IXJ vs XPH: Global Healthcare ETF or Pharma Focus?

XPH delivered 57% returns over one year but swung 31% lower at its worst. IXJ offers steadier performance with higher income and $4.2 billion in assets for easier trading.

Read source
seekingalpha.com /1 month ago

Janus Henderson Global Real Estate Fund Q2 2026 Commentary

Read source
banyanhill.com /3 weeks ago

The Secret Behind +2,261% Day Spike

Isn't it crazy how things change but always stay the same? On Tuesday, Jaguar Health Inc. (JAGX) ran from $2.80 per share at the open to $65.75 in after-hours trading. It created a...

Read source
seekingalpha.com /3 weeks ago

ASG: Deepening Discount Brings Activists

Read source
seekingalpha.com /1 week ago

BrightSpring: Margins Keep Improving While Expanding Its Pharmacy Footprint

Read source
seekingalpha.com /3 weeks ago

JAKKS Pacific: Catalysts Coming In 2027

Read source
seekingalpha.com /1 month ago

Jazz Pharmaceuticals plc (JAZZ) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Read source
seekingalpha.com /1 month ago

SCHG: A Nice Passive Large-Cap Growth ETF, But GARP Is Better

Read source
seekingalpha.com /4 weeks ago

Moberg Pharma AB (publ) (MBGPF) Presents at Redeye Investor Forum Online - Slideshow

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Jsgrx

seekingalpha.com

Recent coverage from public sources
Public source

cafepharma.com

Recent coverage from public sources
Public source

banyanhill.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

fool.com

Recent coverage from public sources
Public source